Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
Fast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in brin...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b25810dbce24dfcb0e2123d0a2ef390 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8b25810dbce24dfcb0e2123d0a2ef390 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8b25810dbce24dfcb0e2123d0a2ef3902021-11-12T06:59:05ZDefining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies1662-453X10.3389/fnins.2021.728092https://doaj.org/article/8b25810dbce24dfcb0e2123d0a2ef3902021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnins.2021.728092/fullhttps://doaj.org/toc/1662-453XFast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in bringing FSCV into clinical use. However, there remain technical challenges that limit clinical implementation of FSCV by creating barriers to appropriate scientific rigor and patient safety. In order to progress with clinical FSCV, these limitations must be first addressed through (1) appropriate pre-clinical studies to ensure accurate measurement of neurotransmitters and (2) the application of a risk management framework to assess patient safety. The intent of this work is to bring awareness of the current issues associated with FSCV to the scientific, engineering, and clinical communities and encourage them to seek solutions or alternatives that ensure data accuracy, rigor and reproducibility, and patient safety.Suelen Lucio BoschenJames TrevathanSeth A. HaraAnders AspAnders AspJ. Luis LujanJ. Luis LujanFrontiers Media S.A.articleclinical neurochemistrydeep brain stimulationfast scan cyclic voltammetryintraoperativeneurochemical signalingneurophysiologyNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Neuroscience, Vol 15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
clinical neurochemistry deep brain stimulation fast scan cyclic voltammetry intraoperative neurochemical signaling neurophysiology Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 |
spellingShingle |
clinical neurochemistry deep brain stimulation fast scan cyclic voltammetry intraoperative neurochemical signaling neurophysiology Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Suelen Lucio Boschen James Trevathan Seth A. Hara Anders Asp Anders Asp J. Luis Lujan J. Luis Lujan Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies |
description |
Fast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in bringing FSCV into clinical use. However, there remain technical challenges that limit clinical implementation of FSCV by creating barriers to appropriate scientific rigor and patient safety. In order to progress with clinical FSCV, these limitations must be first addressed through (1) appropriate pre-clinical studies to ensure accurate measurement of neurotransmitters and (2) the application of a risk management framework to assess patient safety. The intent of this work is to bring awareness of the current issues associated with FSCV to the scientific, engineering, and clinical communities and encourage them to seek solutions or alternatives that ensure data accuracy, rigor and reproducibility, and patient safety. |
format |
article |
author |
Suelen Lucio Boschen James Trevathan Seth A. Hara Anders Asp Anders Asp J. Luis Lujan J. Luis Lujan |
author_facet |
Suelen Lucio Boschen James Trevathan Seth A. Hara Anders Asp Anders Asp J. Luis Lujan J. Luis Lujan |
author_sort |
Suelen Lucio Boschen |
title |
Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies |
title_short |
Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies |
title_full |
Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies |
title_fullStr |
Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies |
title_full_unstemmed |
Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies |
title_sort |
defining a path toward the use of fast-scan cyclic voltammetry in human studies |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/8b25810dbce24dfcb0e2123d0a2ef390 |
work_keys_str_mv |
AT suelenlucioboschen definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies AT jamestrevathan definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies AT sethahara definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies AT andersasp definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies AT andersasp definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies AT jluislujan definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies AT jluislujan definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies |
_version_ |
1718431120511467520 |